A detailed history of Reynders Mc Veigh Capital Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Reynders Mc Veigh Capital Management, LLC holds 21,946 shares of PFE stock, worth $578,496. This represents 0.03% of its overall portfolio holdings.

Number of Shares
21,946
Previous 19,846 10.58%
Holding current value
$578,496
Previous $555,000 14.41%
% of portfolio
0.03%
Previous 0.03%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $58,170 - $65,919
2,100 Added 10.58%
21,946 $635,000
Q2 2024

Aug 13, 2024

SELL
$25.26 - $29.6 $38,774 - $45,436
-1,535 Reduced 7.18%
19,846 $555,000
Q1 2024

May 07, 2024

SELL
$25.89 - $29.73 $9,579 - $11,000
-370 Reduced 1.7%
21,381 $594,000
Q4 2023

Feb 07, 2024

SELL
$26.13 - $33.94 $188,371 - $244,673
-7,209 Reduced 24.89%
21,751 $626,000
Q3 2023

Nov 09, 2023

SELL
$32.09 - $37.51 $154,577 - $180,685
-4,817 Reduced 14.26%
28,960 $961,000
Q2 2023

Aug 09, 2023

SELL
$36.12 - $41.79 $62,343 - $72,129
-1,726 Reduced 4.86%
33,777 $1.24 Million
Q1 2023

May 03, 2023

BUY
$39.39 - $51.28 $122,778 - $159,839
3,117 Added 9.62%
35,503 $1.45 Million
Q4 2022

Feb 10, 2023

SELL
$41.75 - $54.5 $122,995 - $160,557
-2,946 Reduced 8.34%
32,386 $1.66 Million
Q3 2022

Nov 08, 2022

BUY
$43.76 - $53.42 $81,349 - $99,307
1,859 Added 5.55%
35,332 $1.55 Million
Q2 2022

Aug 05, 2022

SELL
$46.53 - $55.17 $169,974 - $201,536
-3,653 Reduced 9.84%
33,473 $1.76 Million
Q1 2022

May 11, 2022

SELL
$45.75 - $56.69 $66,246 - $82,087
-1,448 Reduced 3.75%
37,126 $1.92 Million
Q4 2021

Feb 11, 2022

SELL
$41.32 - $61.25 $20,660 - $30,625
-500 Reduced 1.28%
38,574 $2.28 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $14,012 - $17,999
357 Added 0.92%
39,074 $1.68 Million
Q2 2021

Aug 12, 2021

SELL
$35.91 - $40.68 $748,472 - $847,893
-20,843 Reduced 34.99%
38,717 $1.52 Million
Q1 2021

May 07, 2021

BUY
$33.49 - $37.77 $244,075 - $275,267
7,288 Added 13.94%
59,560 $2.16 Million
Q4 2020

Feb 10, 2021

SELL
$33.47 - $42.56 $220,801 - $280,768
-6,597 Reduced 11.21%
52,272 $1.92 Million
Q3 2020

Oct 28, 2020

SELL
$31.75 - $37.25 $122,237 - $143,412
-3,850 Reduced 6.14%
58,869 $2.16 Million
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $47,679 - $57,842
-1,583 Reduced 2.46%
62,719 $2.05 Million
Q1 2020

May 13, 2020

BUY
$27.03 - $38.62 $18,407 - $26,300
681 Added 1.07%
64,302 $2.1 Million
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $39,339 - $44,645
-1,195 Reduced 1.84%
63,621 $2.49 Million
Q3 2019

Nov 08, 2019

BUY
$32.49 - $42.13 $250,530 - $324,864
7,711 Added 13.5%
64,816 $2.33 Million
Q2 2019

Aug 06, 2019

SELL
$36.98 - $41.52 $48,702 - $54,681
-1,317 Reduced 2.25%
57,105 $2.47 Million
Q1 2019

May 10, 2019

BUY
$37.5 - $41.2 $134,475 - $147,743
3,586 Added 6.54%
58,422 $2.48 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $64,860 - $73,947
-1,686 Reduced 2.98%
54,836 $2.39 Million
Q3 2018

Nov 26, 2018

SELL
$34.47 - $41.81 $108,477 - $131,576
-3,147 Reduced 5.27%
56,522 $2.49 Million
Q2 2018

Aug 09, 2018

BUY
$32.98 - $35.16 $298,930 - $318,690
9,064 Added 17.91%
59,669 $2.17 Million
Q1 2018

Jul 26, 2018

BUY
$31.91 - $37.02 $1.56 Million - $1.81 Million
48,809 Added 2717.65%
50,605 $1.8 Million
Q1 2018

May 03, 2018

SELL
$31.91 - $37.02 $1.46 Million - $1.7 Million
-45,865 Reduced 96.23%
1,796 $50.6 Million
Q4 2017

Feb 06, 2018

SELL
$33.26 - $35.29 $20,388 - $21,632
-613 Reduced 1.27%
47,661 $0
Q3 2017

Nov 09, 2017

SELL
$31.0 - $34.15 $57,660 - $63,519
-1,860 Reduced 3.71%
48,274 $1.72 Million
Q2 2017

Aug 14, 2017

BUY
N/A
50,134
50,134 $1.68 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Reynders Mc Veigh Capital Management, LLC Portfolio

Follow Reynders Mc Veigh Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Reynders Mc Veigh Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Reynders Mc Veigh Capital Management, LLC with notifications on news.